[1] CONNYE N. KURATKO Norman S Jr. Biomarkers of DHA status[J]. Prostaglandins, leukotrienes, and essential fatty acids, 2009, 81 2: Pages 111-118. DOI:
10.1016/j.plefa.2009.05.007[2] R.J.SCOTT LACOMBE Richard P B Rapha?l Chouinard Watkins. Brain docosahexaenoic acid uptake and metabolism[J]. Molecular Aspects of Medicine, 2018, 64: Pages 109-134. DOI:
10.1016/j.mam.2017.12.004[3] CALDER P. Docosahexaenoic Acid[J]. Annals of Nutrition and Metabolism, 2016, 306 1: 8-21. DOI:
10.1159/000448262[4] MARIA C. BASIL Bruce D L. Specialized pro-resolving mediators: endogenous regulators of infection and inflammation[J]. Nature Reviews Immunology, 2015, 16 1: 51-67. DOI:
10.1038/nri.2015.4[5] ILSE A C ARNOLDUSSEN Amanda J K. Impact of DHA on metabolic diseases from womb to tomb.[J]. Marine Drugs, 2014, 12 12: 6190-6212. DOI:
10.3390/md12126190[6] YILONG ZOU. Cytochrome P450 oxidoreductase contributes to phospholipid peroxidation in ferroptosis[J]. Nature chemical biology, 2020, 16 3: 302-309. DOI:
10.1038/s41589-020-0472-6[7] DELPHINE LUMBROSO. Macrophage-Derived Protein S Facilitates Apoptotic Polymorphonuclear Cell Clearance by Resolution Phase Macrophages and Supports Their Reprogramming.[J]. Frontiers in Immunology, 2018: 358. DOI:
10.3389/fimmu.2018.00358[8] ANNE-SOPHIE ARCHAMBAULT. Comparison of eight 15-lipoxygenase (LO) inhibitors on the biosynthesis of 15-LO metabolites by human neutrophils and eosinophils.[J]. PLoS ONE, 2018: e0202424. DOI:
10.1371/journal.pone.0202424[9] BING-QING DENG. Epoxide metabolites of arachidonate and docosahexaenoate function conversely in acute kidney injury involved in GSK3β signaling.[J]. Proceedings of the National Academy of Sciences of the United States of America, 2017: 12608-12613. DOI:
10.1073/pnas.1705615114[10] JENNIFER MILDENBERGER. N-3 PUFAs induce inflammatory tolerance by formation of KEAP1-containing SQSTM1/p62-bodies and activation of NFE2L2.[J]. Autophagy, 2017, 13 10: 1664-1678. DOI:
10.1080/15548627.2017.1345411[11] SEUNG KYUN SHIN. Docosahexaenoic acid-mediated protein aggregates may reduce proteasome activity and delay myotube degradation during muscle atrophy in vitro[J]. Experimental and Molecular Medicine, 2017, 49 1: e287-e287. DOI:
10.1038/emm.2016.133[12] TSUYOSHI YAMAMOTO . Narrow-spectrum inhibitors targeting an alternative menaquinone biosynthetic pathway of Helicobacter pylori[J]. Journal of Infection and Chemotherapy, 2016, 22 9: Pages 587-592. DOI:
10.1016/j.jiac.2016.05.012[13] DANIèLE LUCAS. Stereoselective epoxidation of the last double bond of polyunsaturated fatty acids by human cytochromes P450.[J]. Journal of Lipid Research, 2010, 51 5: 1125-1133. DOI:
10.1194/jlr.m003061